Prednisolone and Morphea - a phase IV clinical study of FDA data
Summary:
Morphea is reported as a side effect among people who take Prednisolone (prednisolone), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Cyclosporine, and have Chronic graft versus host disease.
The phase IV clinical study analyzes which people have Morphea when taking Prednisolone. It is created by eHealthMe based on reports of 211,370 people who have side effects when taking Prednisolone from the FDA, and is updated regularly.
What is Prednisolone?
Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.
What is Morphea?
Morphea is found to be associated with 57 drugs and 132 conditions by eHealthMe. Check the latest studies of Morphea.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
211,370 people reported to have side effects when taking Prednisolone.
Among them, 27 people (0.01%) have Morphea.

Among these 27 people:
How long have people been on Prednisolone when they have Morphea? *
- < 1 month: 33.33 %
- 1 - 6 months: 16.67 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 50.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Morphea when taking Prednisolone? *
- female: 36.36 %
- male: 63.64 %
What is the age of people who have Morphea when taking Prednisolone? *
- 0-1: 0.0 %
- 2-9: 16.67 %
- 10-19: 0.0 %
- 20-29: 11.11 %
- 30-39: 0.0 %
- 40-49: 50.0 %
- 50-59: 11.11 %
- 60+: 11.11 %
What are other drugs people take besides Prednisolone? *
- Cyclosporine: 9 people, 33.33%
- Sorafenib: 5 people, 18.52%
- Tacrolimus: 5 people, 18.52%
- Pantoprazole: 4 people, 14.81%
- Januvia: 3 people, 11.11%
- Metformin: 3 people, 11.11%
- Cosentyx: 3 people, 11.11%
- Jardiance: 3 people, 11.11%
- Difluprednate: 3 people, 11.11%
- Alendronic Acid: 3 people, 11.11%
What are other side effects people have besides Morphea? *
- Rashes (redness): 12 people, 44.44%
- Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 10 people, 37.04%
- Pigmentation Disorder (disturbances of human skin colour): 8 people, 29.63%
- Poikiloderma (pigmentary and atrophic changes in the skin): 7 people, 25.93%
- Joint Range Of Motion Decreased (disease of joint movement): 6 people, 22.22%
- Hyperglycemia (high blood sugar): 5 people, 18.52%
- Dry Eyes (lack of adequate tears): 5 people, 18.52%
- Fatigue (feeling of tiredness): 5 people, 18.52%
- Gastric Ulcer (stomach ulcer): 5 people, 18.52%
- Blood Creatinine Increased: 5 people, 18.52%
What are the existing conditions these people have? *
- Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 6 people, 22.22%
- Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 18.52%
- Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 11.11%
- Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 11.11%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 11.11%
- Gastric Disorder (disease of stomach): 3 people, 11.11%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 11.11%
- Type 2 Diabetes: 3 people, 11.11%
- Pain: 3 people, 11.11%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Prednisolone and have Morphea?
- Check whether Morphea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Prednisolone:
- Prednisolone (212,675 reports)
Morphea treatments and more:
- Morphea (839 reports)
How severe was Morphea and when was it recovered:
Expand to all the drugs that have ingredients of prednisolone:
- Morphea and drugs with ingredients of prednisolone (27 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Prednisolone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Morphea:
- Morphea (57 drugs)
Browse all the conditions that are associated with Morphea:
- Morphea (132 conditions)
Related publications that referenced our studies
- Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
- Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Wellbutrin cause Pvt? - a second ago
- Could Pregabalin cause Bleeding Disorders? - 6 seconds ago
- Drug interactions of Lumigan and Timolol - 9 seconds ago
- Could Lisinopril cause Mycobacterium Chelonae Infection? - 9 seconds ago
- Could Amlodipine cause Breast Enlargement? - 13 seconds ago
- Could Midazolam cause Toxic Skin Eruption? - 14 seconds ago
- Antiviral and Hearing Loss - 14 seconds ago
- Albuterol Sulfate And Ipratropium Bromide vs. Serevent, side effect and effectiveness comparison - 17 seconds ago
- Could Tigan cause Cough Aggravated? - 22 seconds ago
- Drug interactions of Klor-Con and Promethazine Dm - 22 seconds ago